![Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes | Nature Communications Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-24963-3/MediaObjects/41467_2021_24963_Fig1_HTML.png)
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes | Nature Communications
![Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments | ACS Applied Bio Materials Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments | ACS Applied Bio Materials](https://pubs.acs.org/cms/10.1021/acsabm.2c00123/asset/images/large/mt2c00123_0016.jpeg)
Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments | ACS Applied Bio Materials
![SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface | Nature Communications SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-21609-2/MediaObjects/41467_2021_21609_Fig1_HTML.png)
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface | Nature Communications
![Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports](https://www.embopress.org/cms/asset/a4a3e4f7-8479-4907-b840-898fd80eb051/embr202153865-fig-0002-m.png)
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports
![Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy - Methods & Clinical Development Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/6ca7887f-d867-4d10-9e0e-bbea705c83a6/fx1_lrg.jpg)
Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy - Methods & Clinical Development
![A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants | Nature Communications A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-25331-x/MediaObjects/41467_2021_25331_Fig1_HTML.png)
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants | Nature Communications
![PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma - Wang - 2020 - Cancer Medicine - Wiley Online Library PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma - Wang - 2020 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3550aa8c-f5d2-438c-b6a9-f269e7d2878f/cam43331-fig-0001-m.jpg)
PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma - Wang - 2020 - Cancer Medicine - Wiley Online Library
![Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials](https://pubs.acs.org/cms/10.1021/acsabm.2c00573/asset/images/large/mt2c00573_0002.jpeg)
Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials
Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials
![Carnosine improves aging‐induced cognitive impairment and brain regional neurodegeneration in relation to the neuropathological alterations in the secondary structure of amyloid beta (Aβ) - Banerjee - 2021 - Journal of Neurochemistry - Wiley Online Library Carnosine improves aging‐induced cognitive impairment and brain regional neurodegeneration in relation to the neuropathological alterations in the secondary structure of amyloid beta (Aβ) - Banerjee - 2021 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a0f6fa5a-6a45-448b-aa33-a5d56ed1b6cc/jnc15357-fig-0010-m.jpg)
Carnosine improves aging‐induced cognitive impairment and brain regional neurodegeneration in relation to the neuropathological alterations in the secondary structure of amyloid beta (Aβ) - Banerjee - 2021 - Journal of Neurochemistry - Wiley Online Library
![Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c798169c-fd55-43b9-94a2-092367281558/gr1_lrg.jpg)
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine
![The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates | Science Translational Medicine The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates | Science Translational Medicine](https://www.science.org/cms/asset/56e753c7-29f7-47b0-99d5-161a25ef8bf6/abf1906-f1.gif)